Topic
OptraSCAN
News
21 Jul 2026
OptraSCAN Secures US FDA 510(k) Clearance for Integrated Digital Pathology System
OptraSCAN, Inc., a California-based digital pathology and image analysis company majority-held by Molbio Diagnostics Limited since 2025, has received U.S.…
News
18 Aug 2022
Karkinos Healthcare engages OptraSCAN digital pathology for personalised cancer care
The capabilities of this digital pathology platform improve accessibility to healthcare and the distributed care model OptraSCAN, a leading end-to-end…